Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Fabric Protocol Fabric Protocol +18.73%
#4 Cysic Cysic +17.50%
#5 Bedrock Bedrock +10.70%
#6 Cap Cap +8.99%
#7 stake.link stake.link +6.21%
#8 Perle Perle +5.03%
#9 Pons Pons +4.86%
#10 Test Test +4.23%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
주식 순위 #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
주가
$0.00953895
마지막 동기화: 2024-05-22
시가총액
$1.28M
변동 (1일)
0.06%
변동 (1년)
0.00%
국가
GB
거래 Evgen Pharma plc (EVG)

카테고리

Healthcare
Evgen Pharma plc (EVG)의 주가 이력
최고 종가: $0.01 (2024-05-01 기준)

최저 종가: $0.49 (2015-10-01 기준)
Evgen Pharma plc의 주가 이력 (2015 ~ 2026)
연간 주가 성과
연도 성과
2024 -54.58%
2023 -67.00%
2022 -8.24%
2021 -46.45%
2020 34.51%
2019 -54.10%
2018 2.85%
2017 -28.77%
2016 -24.59%
2015 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE